Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
Reading miRNAs for Clinical Meaning
Single miRNAs Don’t Say Much, but They May Become Eloquent Biomarkers if We Take Their Testimony in Context
Sorting Out the CRISPR Patent Case
Sounds of Science Podcast
Good Assays for Bad Immunogenicity
Avoid “Bad” Immunogenicity by Using Assays That Are More Sensitive and Can Adapt to Increasingly Complex and Specialized Drugs
The Sounds of Science podcast is brought to you by GEN. Listen as members of the editorial team—Editor-in-Chief John Sterling, Technical Editor Jeff Buguliskis, and Senior News Editor Alex Philippidis—showcase innovative research, new initiatives, and important policy by interviewing thought-leaders, eminent life-science researchers, and company leaders. These short, but informative podcasts will keep you up-to-date with the latest and most important life science advances.
Bill Warren, partner with the law firm Eversheds Sutherland and chair of its biotechnology and life sciences team, discusses the ruling by a three-judge panel of the Patent Trial and Appeal Board siding with the Broad Institute of MIT and Harvard in the bitter legal battle over who invented CRISPR (clustered regularly interspaced short palindromic repeats) gene-editing technology.
Finding in female mice may also be relevant to certain human psychiatric disorders.
Jodie Morrison, CEO and President of Tokai Pharmaceuticals, is one of nearly 200 biopharma leaders who recently signed an open letter endorsing a Top Ten of best practices for advancing gender diversity, from the boardroom to the C-suite to the lab.
Findings from a new study suggest that the onset of high blood pressure later in life is associated with lower dementia risk after age 90. Listen now for more details!
Entasis Therapeutics is working on novel therapies for serious drug-resistant bacterial infections, a global health crisis affecting the lives of millions of patients.
Benjamin Corb, public affairs director for the American Society for Biochemistry and Molecular Biology (ASBMB), discusses what the biomedical research community can expect from the incoming administration of Donald J. Trump.
The next generation of toys could be controlled by the power of the mind, thanks to researchers at the University of Warwick who have recently developed electronic devices to be activated using electrical impulses from brain waves, by connecting our thoughts to computerized systems.
A new survey led by researchers at Stanford University School of Medicine asked a representative group of adults 65 and older, how willing they would be to learn about their possible cognitive decline. Listen now for more details!
Jay Jackson, manager with Avalere Health, discusses the 21st Century Cures Act, which recently passed both houses of Congress by overwhelming majorities. The measure has long been championed by supporters as a vehicle for speeding up approval of new drugs and maintaining U.S. leadership in research. Critics say the bill does too much for big pharma and not enough for patients seeking relief from rising drug prices.
Scientists in Ireland have solved a mystery regarding the cause of especially smelly camel urine. Their research has implications for the millions of people affected by African parasites called trypanosomes, which frequently cause death from sleeping sickness.
David G. Maloney, M.D., Ph.D., of the Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance, discusses the new Bezos Family Immunotherapy Clinic, a first-of-its-kind facility focused on providing cancer immunotherapies to patients.
Findings from a new retrospective study has found that active marijuana use could increase the risk for developing a rare cardiovascular event.
A new computer analysis from investigators at the MD Anderson Cancer Center suggests that traces of long-lost human cousins may be buried in modern people’s DNA.
Mary Woolley, President of Research!America, which advocates for medical and health research funding, discusses key issues in research that the next president is likely to confront. How can researchers keep those issues on the national agenda no matter who wins on Election Day?
A new study from investigators at The Ohio State University entitled “Gut dysbiosis impairs recovery after spinal cord injury,” describes the impact the gut microbiome has on spinal cord injury and how probiotics could help speed recovery.
One area where biopharma employment has been increasing is in regulatory affairs and compliance.
Quadruple helices appear to have role in switching genes on or off.
Yale University researchers have uncovered the intriguing mechanisms that underlie common sickness behaviors.
Interview with Jon Soderstrom, Ph.D., managing director of the office of cooperative research at Yale University and moderator of the BIO tech transfer session, and Atul Saran, senior vp of corporate development and ventures at MedImmune
Interview with Jim Vaught, Ph.D., Deputy Director, NCI Office of Biorepositories and Biospecimen Research